Sidebar toggle
Podcasts
Video
Articles
Submit PR
Digital Marketing
The BUZZ CRM
Contact
Login
Register
Members
DEA Approves Syndros® THC Oral Solution as Schedule II | cannabisradio
DEA Approves Syndros® THC Oral Solution as Schedule II
Cannabis Radio Live
DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug has received approval for placement in Schedule II classification by the DEA.
Comments
Join in!
Log in
to post comments.
Loading comments...
